Company
Cue Biopharma
Description
Cue Biopharma, Inc. has appointed Lucinda Warren as chief business officer (CBO). With extensive experience in strategic transactions, portfolio optimization, and alliance management, Lucinda Warren will play a pivotal role in advancing Cue Biopharma’s core corporate objectives following the company’s recent business restructuring and autoimmune program prioritization.
Quick answer
Cue Biopharma Appoints Lucinda Warren as Chief Business Officer (September 9, 2024). Cue Biopharma is based in Boston, Massachusetts, United States.
- What did Cue Biopharma announce on September 9, 2024?
- Cue Biopharma, Inc. has appointed Lucinda Warren as chief business officer (CBO). With extensive experience in strategic transactions, portfolio optimization, and alliance management, Lucinda Warren will play a pivotal role in advancing Cue Biopharma’s core corporate objectives following the company’s recent business restructuring and autoimmune program prioritization.
- What does Cue Biopharma do?
- Cue Biopharma, a clinical-stage biopharmaceutical company is developing a novel class of therapeutic biologics to selectively engage and modulate disease-relevant T cells for the treatment of autoimmune disease.
- Where is Cue Biopharma based?
- Cue Biopharma is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- AAVantgarde Bio (September 9, 2024), Solu Therapeutics (September 10, 2024), Tyra Biosciences (September 10, 2024) and Alchemab Therapeutics (September 12, 2024) also announced leadership changes within 45 days of Cue Biopharma.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AAVantgarde Names Jayashree Sahni as Chief Medical Officer (September 9, 2024)
- Solu Therapeutics Appoints Sergio Santillana as Chief Medical Officer (September 10, 2024)
- Tyra Biosciences Appoints Doug Warner, M.D. as Chief Medical Officer (September 10, 2024)
- Jane Osbourn Succeeds Young Kwon as CEO of Alchemab Therapeutics (September 12, 2024)
- NYU Langone Appoints Roxana Fu, MD as Chief of Oculoplastics (September 6, 2024)
- BioCryst Pharmaceuticals Appoints Dr. Donald S. Fong as Chief Medical Officer (September 5, 2024)
Who to call at Cue Biopharma, and when
A new leader at Cue Biopharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cue Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cue Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cue Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cue Biopharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cue Biopharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.